We are live on ! Find out more
AC

Annandale Capital Portfolio holdings

AUM $709M
1-Year Est. Return 11.03%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+11.03%
3 Year Est. Return
+52.53%
5 Year Est. Return
+81.46%
10 Year Est. Return
AUM
$543M
AUM Growth
+$12.8M
Cap. Flow
-$23.1M
Cap. Flow %
-4.25%
Top 10 Hldgs %
45.4%
Holding
147
New
9
Increased
27
Reduced
39
Closed
12

Sector Composition

Rank Sector Weight
1 Communication Services 9.82%
2 Financials 8.99%
3 Consumer Discretionary 6.15%
4 Energy 5.57%
5 Technology 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RF icon
126
Regions Financial
RF
$27.2B
$212K 0.04%
11,200
BA icon
127
Boeing
BA
$190B
$208K 0.04%
1,077
-21
-2% -$4.32K
CEE
128
Central and Eastern Europe Fund
CEE
$138M
$199K 0.04%
20,928
LL
129
DELISTED
LL Flooring Holdings, Inc.
LL
$193K 0.04%
105,446
-44,554
-30% -$108K
OESX icon
130
Orion Energy Systems
OESX
$61.9M
$185K 0.03%
21,241
-2,984
-12% -$29.4K
KRP icon
131
Kimbell Royalty Partners
KRP
$1.43B
$180K 0.03%
11,586
+258
+2% +$3.92K
CRK icon
132
Comstock Resources
CRK
$3.84B
$154K 0.03%
+16,574
New +$136K
WWR icon
133
Westwater Resources
WWR
$53.6M
$123K 0.02%
250,000
-50,000
-17% -$25.8K
RYAN icon
134
Ryan Specialty Holdings
RYAN
$5.79B
$72K 0.01%
15,000
APTO
135
DELISTED
Aptose Biosciences, Inc.
APTO
$44K 0.01%
889
-1,600
-64% -$91.5K
AM icon
136
Antero Midstream
AM
$10.1B
-98,800
Closed -$1.24M
AR icon
137
PUT
Antero Resources
AR
$10.6B
-700,000
Closed -$13.3M
CGEM icon
138
Cullinan Oncology
CGEM
$1.07B
-12,000
Closed -$122K
CRL icon
139
Charles River Laboratories
CRL
$12.6B
-7,900
Closed -$1.87M
CUE icon
140
Cue Biopharma
CUE
$112M
-2,167
Closed -$172K
DG icon
141
Dollar General
DG
$28.1B
-36,627
Closed -$4.98M
DG icon
142
PUT
Dollar General
DG
$28.1B
-25,000
Closed -$3.13M
DHR icon
143
Danaher
DHR
$139B
-2,600
Closed -$601K
ELEV
144
DELISTED
Elevation Oncology
ELEV
-50,000
Closed -$27K
MMM icon
145
3M
MMM
$94.4B
-65,114
Closed -$5.95M
MMM icon
146
PUT
3M
MMM
$94.4B
-59,920
Closed -$4.26M
XERS icon
147
Xeris Biopharma Holdings
XERS
$1.39B
-55,820
Closed -$131K

Similar funds

Annandale Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Annandale Capital held 147 positions worth $543M, up 2.4% from $530M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Annandale Capital withdrew a net $23.1M in Q1 2024, closing 12 positions and reducing 39 holdings. Its most notable exit was 3M, an estimated $5.95M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 9.8% of assets, up from 8.1% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Annandale Capital opened a new position in Baidu worth $2.06M.

  • Annandale Capital's largest Q1 2024 buy was Baidu: 19,596 shares worth $2.06M.
  • Annandale Capital added most to Dimensional US Core Equity 1 ETF in Q1 2024, an estimated $2.29M increase.
  • Annandale Capital's biggest Q1 2024 reduction was Antero Resources, cutting an estimated $17.8M.
  • Annandale Capital fully exited 3M in Q1 2024, selling an estimated $5.95M.
  • Annandale Capital's ten largest holdings make up 45% of its $543M portfolio in Q1 2024.
  • Annandale Capital opened 9 new positions and closed 12 in Q1 2024.
  • Annandale Capital's portfolio value rose 2.4% quarter-over-quarter to $543M.

Based on Annandale Capital's 13F filing for Q1 2024, filed 15 May 2024.